Skip to main content
Skip to footer
Home
News Channels
Antibodies
Proteins and Peptides
Vaccines
DNA RNA and Cells
Small Molecules
More News
All News
Reports
Press Room
Contact Us
About Us
All Categories
Antibodies
DNA RNA and Cells
More News
Proteins and Peptides
Small Molecules
Vaccines
Any Word
All Words
Exact Phrase
TCR T-Cells and Antibodies
Feb 2023
Antibody Target, Technology & Pipeline Database: 1-Year Subscription
1.600,00€
May 2020
Report Package: “Drug the Undruggable” Technologies
8.250,00€
4.125,00€
May 2018
Report Package: TCR-Based Antibody and T-Cell Immunotherapy
4.450,00€
2.670,00€
May 2018
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals
2.150,00€
Jan 2018
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
2.300,00€
2.000,00€
Any Word
All Words
Exact Phrase
Report categories
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells
Drug the Undruggable Technologies
Immuno-Oncology
mRNA Vaccines & Therapeutics
NK Cells & CAR Macrophages
Pipeline Database
RNA-Targeted Therapeutics
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Antibodies
Therapeutic Proteins & Peptides
